The hornet’s story in Europe began quietly in 2004, when a queen, possibly just a single individual, was accidentally transported from China to France. Genetic analyses suggest this tiny founding population was enough to seed an invasion. By 2017, Vespa velutina had colonized nearly all of France, and from there it spread with remarkable speed: Spain in 2010, Portugal in 2011, Italy in 2013, Germany in 2014, and the United Kingdom in 2016. By 2020, individuals were turning up in Switzerland, the Netherlands, and Ireland. More recently, nests were discovered in 2023 in the Czech Republic and Hungary, and in Slovakia in 2024, while a lone individual was recorded in Austria. The invasion has now jumped continents, with the first colonies found near Savannah, Georgia, in the United States in 2023, and queens reported in New Zealand in November 2025.

The ecological and economic stakes are high. Vespa velutina hunts honeybees, locates apiaries, and decimates colonies, threatening local beekeeping operations and the livelihoods tied to them. It also preys on pollinators and decomposers more broadly, feeds on fruit, and reduces the abundance of insects that underpin ecosystem functioning. Because rising temperatures across Europe are expected to accelerate its spread, researchers emphasize that continuous efforts to stop or slow the invasion are urgently needed. Management typically operates on three levels: prevention, early detection, and eradication. Successful eradications have been achieved in the United Kingdom and on the Spanish island of Mallorca, but these victories depended on rapid detection and the elimination of every nest before the population could gain a foothold.

This is where public engagement becomes critical, and where current approaches fall short. Citizen reporting dramatically expands the area under surveillance, but the general public turns out to be surprisingly poor at identifying the hornet. In Guernsey, only 16.8 percent of public reports over three years were correct identifications. Other studies estimated public accuracy at roughly 30 percent, and among visitors at a bee festival, a motivated and experienced audience, only 33 percent identified the species correctly. In Mallorca, despite a successful eradication, a specially developed reporting app was downloaded by fewer than 3,700 people, less than half a percent of the island’s population. The researchers behind the new study identified two main bottlenecks: only a small fraction of the public is even aware of the threat, and those who do report often misidentify the species, complicating nest searches and wasting expert resources.

To test whether education could overcome these barriers, the team developed a targeted program for pupils aged 10 to 11 in České Budějovice, a South Bohemian city that the hornet has not yet reached but where its arrival is considered highly probable. Twenty classes took part between October and December 2024. The curriculum covered the hornet’s biology, its ecological and economic impacts, and its key identification features, with a strong emphasis on practical demonstration. Crucially, instead of photographs, the children examined real specimens embedded in transparent resin, including Vespa velutina workers and commonly confused native species such as the common wasp, the German wasp, and the European hornet. Handling resin-embedded insects avoided the fear or disgust that direct contact with stinging insects might provoke, while physical specimens helped prevent the misidentification errors that images alone can cause. A leaflet with a reporting telephone number was displayed in classrooms, and pupils without phones were encouraged to report sightings through their teachers.

The educational impact was measured rigorously. Pupils completed a short pre-test immediately before the program, the same test one week afterward, and a follow-up test two to three months later. Statistical analysis using repeated-measures ANOVA revealed a highly significant improvement in both knowledge scores and identification accuracy, with p-values below 0.001 in each case. Importantly, the gains were retained months later, indicating that the information had entered long-term memory. Before the program, awareness of the hornet was almost entirely limited to children already involved in beekeeping through their families. Afterward, the majority could correctly recognize the invasive species and distinguish it from its harmless native look-alikes.

The most striking test came six months after the program, in June 2025, when the researchers placed a dead Vespa velutina specimen on the classroom windowsill in participating schools. Fourteen of the twenty teachers consented to this covert experiment, and school staff were instructed not to alert pupils or remove the specimen during cleaning. The dead hornet sat in plain view for up to five consecutive days. In nine of the fourteen classes, or 64.3 percent, its presence was reported. Five classes reported it on the very first day, and four more the following day. In one memorable case, a pupil noticed the specimen on day one, took it home for careful examination overnight, and reported it to the teacher the next morning after confirming the identification. The scenario deliberately mimicked real-world conditions: the first recorded observation of the hornet in Austria in 2024 was a dead individual found on a hospital windowsill, and a hornet trapped indoors over a weekend would plausibly end up in exactly the same way.

Just as important as the successful detections was what did not happen next. Three months later, in September 2025, the researchers repeated the experiment with a dead European hornet, Vespa crabro, a large native vespid frequently mistaken for the invader. Not a single false report of Vespa velutina came in, either from the trained classes or from five additional classes that had not taken part in the earlier phase. The children had not merely learned to flag anything big and striped; they had learned the diagnostic features well enough to hold their fire when the wrong species appeared. This precision addresses one of the most persistent weaknesses of citizen science programs, in which floods of inaccurate reports raise verification costs and erode the value of public data.

The authors acknowledge limitations. The practical assessment ran in only fourteen classrooms, which constrained the original design of simultaneously testing the invasive and native species in different rooms. Because the control phase took place after the summer holidays, class compositions had shifted slightly, with most pupils retained but some turnover in a few classes. The study also tested recognition of dead specimens rather than flying hornets or individuals feeding on fruit, a constraint imposed by safety considerations and the need for a realistic simulation. Still, the researchers argue that June and September are comparable testing windows, since children are distracted at the end of the school year just as they are readjusting at the start of a new one, and attention to the hornet had already waned by the time of the June test.

The broader implications reach well beyond one Czech city. School-based programs are cheap, easy to implement, and can rapidly create hundreds of informed observers who understand the threat and know how to report it. Even if only a fraction of trained children remain vigilant over time, the sheer numbers involved mean that reliable reports could increase substantially, easing the shortage of citizen scientists and reducing the expert verification burden that drives up eradication costs. Involving children in a genuine, consequential task also boosts motivation and awareness, benefits that extend beyond biosecurity. The researchers recommend repeating such programs yearly, potentially woven into science curricula on invasive species, and deploying them urgently in Central European countries at the invasion front, such as Austria, Slovakia, and Hungary, as well as in the United States, New Zealand, and Mexico, where the hornet has arrived or is expected. In regions where the related and even more dangerous Asian giant hornet, Vespa mandarinia, is beginning to spread, educational content could cover both species. As warming climates push invasive hornets into new territory, the study suggests that the frontline of early detection may run straight through the classroom, where a modest investment in education can yield a distributed, accurate, and motivated detection network at almost no cost.

Subject of Research: School-based education programs for early detection of the invasive yellow-legged hornet Vespa velutina

Article Title: Children as frontline detectors: School-based programs can enhance early monitoring of Vespa velutina

Article References: Ditrich, T., & Lustová, Š. (2025). Children as frontline detectors: School-based programs can enhance early monitoring of Vespa velutina. NeoBiota, 104, 381-392. https://doi.org/10.3897/neobiota.104.174530

Image Credits: AI Generated

DOI: 10.3897/neobiota.104.174530

Keywords: Vespa velutina, yellow-legged hornet, invasive species, citizen science, early detection, school education, biological invasions, apiculture, pollinators, Czech Republic, species identification, eradication

The study, published in the journal NeoBiota, used a Monte Carlo simulation model to project how the wasp’s spread would ripple through three sectors: horticulture, wine grape production, and private households. The researchers assumed no coordinated eradication or containment effort would be mounted, creating a worst-case baseline against which future government interventions could be measured. Their conclusion is stark: doing nothing carries a price tag equivalent to roughly US$3–6 million every year, which sets a clear ceiling on what a rational eradication or spread-mitigation program should cost.

Vespula germanica is no stranger to invasion biology. Since World War II, increased movement of people and cargo has carried it from its native range to North America, Argentina, Chile, Iceland, New Zealand, Australia, and South Africa. It was first recorded in the Western Cape in 1972, though it may have arrived before 1970. Genetic analysis suggests two separate incursion events: a dominant haplotype, Hap2, established around the Cape Peninsula, while a second haplotype, Hap1, appears to have arrived in the Boland region northeast of Cape Town around the year 2000 and has since spread north, east, and south. Researchers suspect Hap1 is better suited to the local climate, raising concerns about faster expansion in the decades ahead.

What makes the wasp particularly dangerous to agriculture is its appetite for honeybees. Workers attack both wild and managed colonies of the European honeybee, Apis mellifera, sometimes raiding hives directly but more often picking off individual bees at ground level. South Africa is unusually vulnerable to this kind of pressure. Wild pollinators currently supply only about one fifth of the pollination services that fruit and vegetable growers need, and managed hive rental services are already insufficient to meet peak seasonal demand. Because growers cannot easily substitute other pollination sources, demand for hive rentals is highly inelastic, meaning any reduction in commercial hive capacity translates almost directly into higher costs for farmers.

The simulation modeled fourteen horticultural industries, from apples and pears to macadamia nuts, avocados, and strawberries, covering roughly 220,000 hectares and a gross value of about US$1.6 billion. As wasp predation shrinks the effective supply of commercial hives, the model predicts hive hire prices will climb. For the first 25 to 30 years the effect is negligible, but after 50 years the price per hive is projected to rise from US$75.00 to between US$78.20 and US$84.50, while yield losses in pollinator-dependent crops increase by 4 to 13 percent. Over the full simulation period, these pollination disruptions are expected to cost the horticulture sector US$30–55 million.

Wine grapes face a different kind of threat. German wasps hollow out grapes on the vine, causing direct yield losses and introducing foreign yeasts that interfere with fermentation. In unmanaged vineyards elsewhere, losses of 10 to 15 percent have been recorded. South African wine grape production spans about 87,850 hectares, concentrated in the Cape Winelands around Stellenbosch, Paarl, Franschhoek, and Constantia, and was valued at roughly US$393 million in 2022/23. The model assumes vineyard managers would respond by deploying bait stations at around five per hectare, costing US$120–150 per hectare annually, which suppresses damage to negligible levels. Even so, the cumulative cost of this control effort over 50 years is estimated at US$1–3 million, a relatively minor share of the total.

By far the largest burden falls on households. In warm climates, German wasp colonies can breed continuously and grow to contain many thousands of individuals by late summer, making them a serious nuisance and health hazard in urban areas. The researchers assumed that 5 percent of urban wasp colonies would pose enough of a risk to residents’ health and recreation to justify professional pest control, and that about 20 percent of South Africa’s 18.5 million dwellings fall into the middle-class category with sufficient disposable income to hire such services. At an assumed cost of US$120–300 per nest removal, household pest management expenses are projected to reach US$110–260 million over 50 years, accounting for a striking 82 percent of all modeled damages.

The model’s sensitivity analysis revealed which variables matter most. The results were overwhelmingly driven by the assumed rate of spread: stretching the time for the wasp to saturate each sector to 50 years cut the median damage estimate from US$225 million to US$115 million, while compressing it to 30 years pushed the figure up to US$345 million. The discount rate came a close second, with a one-percentage-point shift moving the median estimate by roughly 30 to 50 percent. This sensitivity cuts both ways: it means the projections carry real uncertainty, but it also means that even modest investments in slowing the wasp’s spread could yield enormous returns.

The authors argue this is precisely where the policy value lies. If a spread-mitigation program, whether nest surveillance, subsidies for pest control, bounties for reporting, or biological control, can push the spread timeline out to 50 years, it would avert about US$110 million in damages over 30 years, or roughly US$3.7 million per year. Any program costing less than that threshold produces a net benefit for society. Given that eradication may still be technically feasible thanks to the wasp’s historically slow expansion, the study effectively hands South African policymakers a price tag for inaction and a benchmark for action.

There are caveats. The model is deliberately aspatial, treating spread as a smooth logistic curve even though the wasp’s actual expansion has been sporadic, driven partly by human-mediated transport. It also assumes the supply of managed hives stays constant, reflecting real barriers: South Africa has banned live honeybee imports since the early 1980s, wild bee stock is limited, and forage resources in the dry climate are constrained. Adding a spatial dimension through dispersal or cellular automata models could sharpen regional predictions. But as a first estimate of what an unmanaged invasion would cost, the message is clear: the German wasp’s bill is coming, and the cheapest time to stop it is now.

Subject of Research: Economic impact modeling of the invasive German wasp Vespula germanica in South Africa

Article Title: Potential future economic impact of Vespula germanica (Fabricius) ( Hymenoptera , Vespidae ) in South Africa

Article References: Cook, D. C., McKirdy, S. J., & Veldtman, R. (2026). Potential future economic impact of Vespula germanica (Fabricius) (Hymenoptera, Vespidae) in South Africa. NeoBiota, 109, 67-84. https://doi.org/10.3897/neobiota.109.191014

Image Credits: AI Generated

DOI: 10.3897/neobiota.109.191014

Keywords: Vespula germanica, invasive species, South Africa, pollination, horticulture, wine grapes, household pest control, Monte Carlo simulation, economic modeling, NeoBiota, eradication, biosecurity

The scale of the invasion itself is staggering. In western North America, more than 95 percent of larger, deeper high-elevation lakes contain non-native trout, according to earlier surveys cited in the review. In the Pyrenees, invasive fish occupy between 35 and 85 percent of lakes. Introductions of game fish such as trout date back to the Middle Ages in the Pyrenees and to the fifteenth century in the Alps, and they continue today, often promoted by state fisheries agencies and fishing organizations. The researchers conclude that introduced invasive fish may be the single most critical threat to mountain lake biodiversity, driving declines in native fish, amphibians, invertebrates, and zooplankton, and reshaping entire food webs.

The ecological consequences extend far beyond simple predation. Introduced fish displace and extinguish native species, alter trophic interactions, disrupt nutrient cycling, degrade habitats, hybridize with local populations, and transmit diseases and pathogens. Because fish accumulate atmospherically deposited toxins in their tissues, non-native trout in previously fishless lakes can even pose a health risk to wildlife and to anglers who eat their catch. Recent studies have documented that introduced fish reduce the occurrence of shrews in alpine lakes and that non-native minnows cause far larger negative effects on littoral macroinvertebrates than trout do. The message from the literature is unambiguous: fishless mountain lakes are not empty ecosystems waiting to be stocked, but unique habitats harboring species with extraordinary adaptations to harsh conditions.

To map the state of knowledge, the team executed a two-stage search of the Web of Science database, first with a naïve set of 84 expert-provided search terms and then with a refined string built from 343 selected keywords extracted from the initial results. They used the R package litsearchr to identify keywords, drew geographic terms from the hierarchically organized GMBA Mountain Inventory covering more than 8,000 mountain ranges, and validated species names against the GBIF backbone taxonomy. After removing duplicates and screening thousands of records, the initial searches returned 1,278 and 1,920 publications respectively, but only 35 papers survived strict eligibility criteria. These described 184 distinct cases, each a unique combination of a single species at a single location, across 96 aquatic ecosystems ranging from 300 to 3,600 meters above sea level, in size from 0.35 to 34,020 hectares, and up to 133 meters deep.

The geographic and taxonomic biases in this literature are striking. Seventy-seven percent of the studies were conducted in North America, primarily in the western United States and the Canadian Rockies, while 17 percent came from Europe, concentrated in the Italian Alps, the Pyrenees, and Austria. Only a single study came from Asia, despite the vast extent of mountain terrain there. Taxonomically, salmonids dominated: the brook trout, Salvelinus fontinalis, appeared in 21 papers and the rainbow trout, Oncorhynchus mykiss, in 12. Cyprinids such as the golden shiner and minnows formed the second most targeted group. All the targeted species were ecological generalists with broad temperature tolerance and life-history strategies, such as high reproductive output or early sexual maturity, that enhance survival and population growth in harsh environments.

When it comes to actual removal techniques, the review found that physical methods dominated the published record, accounting for 57 percent of approaches, followed by chemical methods at 31 percent and biological methods in a small minority. Within the physical category, gill netting and electrofishing were the workhorses, often deployed over months or, in one long-term American program, over 11 years. Chemical treatments relied overwhelmingly on rotenone, a piscicide that kills fish by blocking oxygen uptake in their gills, with antimycin and deoxygenation agents such as organic matter used more rarely. Biological approaches involved introducing predators or genetically modified individuals. Combined approaches appeared in only two papers, pairing techniques such as shoreline trap nets with predator introduction or integrating drainage, multiple net types, electrofishing, and rotenone.

Success rates varied considerably by method. Among the 157 cases where outcomes were reported, full eradication was achieved in 58 percent. Chemical approaches proved the most effective, with 80 percent of cases ending in eradication, and within salmonids, the best-studied group, 27 of 29 chemical treatment cases resulted in complete removal. Physical methods, though used far more often, achieved eradication in 60 percent of cases overall and only 48 of 77 salmonid cases. Yet the authors caution against a simple prescription, because chemical methods carry serious drawbacks. Rotenone and similar piscicides are not species-specific: they kill native fish alongside invaders and are toxic to other organisms, including amphibians. In the European Union, rotenone has been banned since 2008 and antimycin is not approved, while in the United States its use is tightly regulated with criminal penalties for violations. Physical gear, by contrast, requires no special permits and overlaps with the routine toolkit of fisheries managers, which helps explain its popularity despite lower efficacy.

Method selection also followed the goals of each intervention. When the objective was recovering amphibians, invertebrates, or entire ecosystems, managers favored physical approaches almost exclusively. When the goal was restoring native fish populations, chemical methods dominated, presumably because wholesale fish removal was acceptable where restocking with native species was planned. Most of the reviewed studies, 19 of 35, aimed at recovering native ecosystems and their communities, while 12 were methodological assessments of removal efficiency. Government institutions led the vast majority of campaigns, working alone in 17 of the 20 papers that reported stakeholders, and collaborating with researchers and volunteers in the remaining three.

The review also exposes practical and economic realities that shape what is possible in remote terrain. Rotenone treatments in Norway have been estimated to cost between 10,000 and more than 200,000 euros per year depending on the species and site, with most expenses tied to labor. Motorized electrofishing equipment runs roughly 6,000 to 20,000 euros, nets cost from just over 100 to around 1,000 euros per unit, and helicopter flights to inaccessible lakes add substantial expense. Cost information is chronically underreported, making cost-benefit analysis difficult. The authors argue that collaborative approaches among landowners and stakeholders, watershed-scale prioritization, and treating mountain lakes as social-ecological systems can help optimize investments, but they also note that wilderness fishing carries deep cultural value, making public support for eradication both crucial and hard to win.

Perhaps the review’s most important conclusions concern what happens when eradication is impossible or undesirable. Where populations are dense or lakes are large, suppression strategies, reducing invaders below the threshold at which they cause harm, can still deliver conservation gains, an approach the authors call functional eradication. Prevention, early detection through tools such as environmental DNA surveillance, and rapid intervention before invaders become established remain the most affordable and effective strategy by far. To close the knowledge gap they documented, the team compiled a trait database covering the taxonomy, life history, ecology, and invasiveness potential of targeted species, and built the FishME Toolbox, an open-access online platform hosted within the GMBA Mountain Portal that links publications, species, and study sites for both experts and the general public. As fish introductions continue to rise and climate change reshapes mountain waters, the authors hope that learning systematically from past interventions, including failures that often go unpublished, will guide smarter, faster, and more adaptive management of some of the planet’s most vulnerable freshwater ecosystems.

Subject of Research: Removal of introduced fish from mountain lentic ecosystems

Article Title: Introduced Fish in Mountains: State of Published Research on their Removal from Lentic Ecosystems

Article References: Cogălniceanu, D., Stănescu, F., Tănase, T. L., Vlad, S. E., Snethlage, M., Ranipeta, A., & Urbach, D. (2026). Introduced Fish in Mountains: State of Published Research on their Removal from Lentic Ecosystems. Environmental Management, 76(9), Article 304. https://doi.org/10.1007/s00267-026-02616-9

Image Credits: AI Generated

DOI: 10.1007/s00267-026-02616-9

Keywords: invasive fish, mountain lakes, eradication, rotenone, salmonids, gill netting, electrofishing, biodiversity conservation, lentic ecosystems, FishME Toolbox, systematic review, early detection

Peptic ulcer bleeding, often abbreviated PUB, is one of the most feared complications in gastroenterology. It occurs when an open sore in the lining of the stomach or the first part of the small intestine erodes into a blood vessel, producing external digestive hemorrhage or a drop in hemoglobin greater than two grams per deciliter. Despite major advances in endoscopic therapy and acid suppression over the past two decades, patients who experience one such bleed remain at elevated risk of another. For those also taking antithrombotic medications—drugs such as antiplatelet agents and anticoagulants that are essential for preventing heart attacks and strokes—the calculus becomes even more delicate, because both the ulcer and the cardiovascular system compete for clinical attention.

The conventional wisdom, embedded in multiple international guidelines, holds that eradicating H. pylori, a spiral-shaped bacterium that colonizes the gastric mucosa and is a principal cause of peptic ulcer disease, is a cornerstone of preventing recurrent bleeding. Yet much of the evidence underpinning that recommendation predates the era of widespread, long-term proton pump inhibitor use, the powerful acid-suppressing drugs that have become near-universal prescriptions after a bleeding event. The Spanish team set out to test whether the bacterium still drives recurrence in a contemporary, real-world population in which acid suppression is the norm rather than the exception.

To answer the question, the investigators conducted a retrospective, multicenter cohort study of consecutive patients who suffered a first episode of peptic ulcer bleeding between 2008 and 2023 in real clinical settings across Spain. To be included, patients required endoscopically confirmed gastric or duodenal ulcers or erosions together with evidence of bleeding. Those with non-peptic causes of upper gastrointestinal hemorrhage, peptic ulcers without bleeding, bleeding from the small bowel or colon, missing clinical data, or death during the index hospitalization were excluded. Follow-up continued until the first recurrence of ulcer bleeding, death, loss to follow-up, or the end of the review period, yielding a mean observation time of 6.4 years with a standard deviation of 4.7 years—a remarkably long window for a study of this kind.

The cohort ultimately comprised 1,675 patients. At discharge after their first bleeding episode, 525 of them, or 31 percent, were prescribed antithrombotic therapy, while 1,021 patients, or 61 percent of the entire cohort, received long-term proton pump inhibitor prescriptions. Notably, among the antithrombotic users themselves, 429 patients, representing 82 percent, were given indefinite PPI therapy, underscoring just how thoroughly acid suppression has penetrated routine care for this group. After the initial bleed and any eradication treatment, 94 patients, or 5.6 percent, remained H. pylori-positive, 936 patients, or 56 percent, tested negative, and 645 patients, or 38 percent, were never tested for the bacterium—a sizable untested fraction that itself reflects themessiness of real-world medicine.

The headline finding for the whole cohort was striking. Overall, 7.2 percent of patients experienced a first recurrence of peptic ulcer bleeding during follow-up. But when the researchers stratified by H. pylori status, recurrence climbed to 22 percent among those who remained positive, fell to 7.7 percent among those who were negative, and dropped to just 4.2 percent among the untested. Using Cox regression analysis adjusted for age, sex, use of non-steroidal anti-inflammatory drugs, and long-term PPI prescription, the team calculated that patients who stayed H. pylori-positive had a 3.7-fold higher risk of recurrence compared with H. pylori-negative patients, with a 95 percent confidence interval of 2.3 to 6.1. When the comparison was restricted to patients who remained positive versus those who had been successfully eradicated, the risk was 4.7 times higher, with a confidence interval of 2.6 to 8.7. In other words, in the general population of bleeders, the bacterium remains a potent and measurable driver of recurrent hemorrhage.

The picture changed dramatically, however, when the researchers turned to the 525 patients on antithrombotic drugs. In this subgroup, the overall incidence of first recurrence was only 5.1 percent. Among H. pylori-positive antithrombotic users, recurrence reached 7.1 percent; among H. pylori-negative users, 8 percent; and among the untested, just 2 percent. Counterintuitively, the positive patients did not fare worse than the negative ones, and after statistical adjustment the team found no significant risk differences across H. pylori status groups. The wide confidence intervals that accompany such subgroup analyses temper any strong claims, but the signal is clear: within this heavily PPI-protected population, H. pylori status no longer predicted who would bleed again.

What might explain this apparent paradox? One plausible mechanism centers on gastric acidity itself. H. pylori promotes ulcer formation and recurrence partly through inflammation and disruption of the mucosal barrier, but acid secretion remains a critical cofactor in the cascade that turns a colonized stomach into a bleeding ulcer. Proton pump inhibitors suppress acid output profoundly and durably, and with 82 percent of antithrombotic users in this cohort taking them indefinitely, the pharmacological floor beneath the mucosa may be high enough that eradicating the bacterium adds little additional protection. In patients without such acid suppression, or in whom PPI therapy is intermittent, the bacterium retains its full pathogenic force—precisely the pattern the whole-cohort analysis revealed. The finding also echoes a broader shift in ulcer epidemiology: as H. pylori prevalence falls and non-steroidal anti-inflammatory drug and antithrombotic use rises, drug-induced mucosal injury has overtaken infection as the dominant cause of bleeding ulcers in many settings.

The authors are careful to frame their work as preliminary, and several limitations deserve attention. The retrospective design means the researchers depended on records and testing practices that varied across centers and years, and the 38 percent of patients never tested for H. pylori introduce the possibility of selection effects—clinicians may have been less likely to test patients they judged to be at low risk. The antithrombotic subgroup, though sizable at 525 patients, yielded relatively few recurrence events, which limits statistical power and widens uncertainty around the null finding. Confounding by indication is also possible, since patients receiving antithrombotics differ systematically from those who do not. The study’s ethics approval came from the ethics committee of Aragón under code EPA22/065, with the informed consent requirement waived owing to the observational design, and the statistical analysis was supported by the Group of Translational Research in Digestive Diseases of the Aragón Health Research Institute, the CIBERehd network, and the FORTALECE program of the Spanish Ministry of Science and Innovation.

Even with those caveats, the implications are hard to ignore. Millions of people worldwide take antithrombotic drugs for cardiovascular protection, and a meaningful share of them carry H. pylori or have uncertain infection status. If prolonged acid suppression largely neutralizes the bacterium’s contribution to recurrent bleeding in these patients, clinicians may be able to prioritize adherence to PPI therapy, careful antithrombotic dosing, and avoidance of non-steroidal anti-inflammatory drugs over exhaustive pursuit of eradication in every case. At the same time, the stark 3.7-fold elevation in recurrence risk among H. pylori-positive patients in the broader cohort is a vivid reminder that eradication remains essential for most survivors of ulcer bleeding. The study does not overturn the eradication paradigm; it carves out a well-defined exception and, in doing so, maps the boundary conditions of one of gastroenterology’s most durable beliefs. Larger prospective studies, ideally with systematic testing of all patients, will be needed to confirm where that boundary truly lies—but for now, the message from Spain is that in the modern, acid-suppressed, real-world clinic, the bacterium’s grip on bleeding risk may be loosening, at least for those whose hearts and vessels demand blood thinners.

Subject of Research: Helicobacter pylori status and recurrence of peptic ulcer bleeding in antithrombotic users

Article Title: No significant association between H. pylori status and peptic ulcer bleeding recurrence among antithrombotic users: a preliminary study in a real-world population with high PPI use

Article References: Martínez-Domínguez, S. J., Ceamanos-Ibarra, E., Gallego-Llera, B., Jiménez-Benedí, M., Bujanda, L., Jardón-Piérola, O., Izaguirre-Arostegi, A., Cuarán, C., Pascual, A., Almenara, L., & Lanas, Á. (2026). No significant association between H. pylori status and peptic ulcer bleeding recurrence among antithrombotic users: a preliminary study in a real-world population with high PPI use. BMC Medicine. https://doi.org/10.1186/s12916-026-05275-z

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05275-z

Keywords: Helicobacter pylori, peptic ulcer bleeding, antithrombotics, proton pump inhibitors, gastrointestinal bleeding, ulcer recurrence, Cox regression, retrospective cohort study, NSAIDs, eradication, BMC Medicine, gastroenterology

Helicobacter pylori remains one of the most consequential human pathogens on the planet, colonizing the gastric mucosa of roughly half the world’s population and serving as the dominant risk factor for peptic ulcer disease, chronic gastritis, and gastric adenocarcinoma. Eradicating the bacterium has become progressively harder over the past two decades as clarithromycin and levofloxacin resistance has spread, pushing clinicians toward bismuth quadruple therapy and, more recently, toward dual therapies that pair a potent acid suppressant with high-dose amoxicillin. The logic of these dual regimens is elegant: by driving intragastric pH sharply upward, the acid blocker undermines H. pylori’s ecological niche and enhances amoxicillin’s stability and activity against actively dividing bacteria, while restricting the antibiotic arsenal to a single agent helps preserve susceptibility of other organisms. The arrival of vonoprazan, which binds reversibly to the gastric H+/K+-ATPase at a potassium-binding site and achieves faster, stronger, and more sustained acid inhibition than classical proton pump inhibitors, has energized this strategy, but direct comparisons with optimized proton pump inhibitor dual regimens have remained limited, particularly regarding collateral effects on the gut microbiome.

To address that gap, the research team enrolled a total of 110 H. pylori-positive patients and non-randomly assigned them to one of two fourteen-day-style dual regimens. Fifty patients received the P-CAB regimen, consisting of vonoprazan 20 milligrams twice daily combined with amoxicillin 750 milligrams four times daily, while sixty patients received the PPI regimen, comprising esomeprazole 20 milligrams four times daily with the same amoxicillin dosing. Twenty-two H. pylori-negative individuals served as healthy controls for microbiota benchmarking. Eradication success was determined four weeks after completion of therapy using the 13C-urea breath test, a noninvasive assay that exploits the bacterium’s urease enzyme to detect active infection. The investigators also gathered fecal samples at three time points, baseline before treatment, roughly two weeks into the post-therapy window, and at week six, to characterize shifts in microbial diversity, community composition, and predicted functional pathways through 16S rRNA gene sequencing.

On the pharmacological front, the two acid suppressants differ in ways that matter clinically. Proton pump inhibitors such as esomeprazole are acid-activated prodrugs that require an acidic environment to engage the pump irreversibly, meaning their effect accumulates over several doses and is blunted in the very hypersecretory or proton-pump-dense patients who most need acid control. Vonoprazan, by contrast, is active at neutral pH, accumulates in parietal cells, and exerts dose-dependent, reversible inhibition that reaches near-anacidic gastric conditions within hours and persists through once- or twice-daily dosing. That kinetic advantage is thought to explain why vonoprazan-based dual therapy performs well even in regions with high amoxicillin resistance, since sustained acid suppression amplifies amoxicillin’s bactericidal window. The esomeprazole arm in this study used a four-times-daily schedule specifically to maximize acid suppression and keep the comparison fair against the twice-daily vonoprazan regimen.

The headline efficacy finding favored vonoprazan across every analysis population. The P-CAB group achieved an eradication rate of 97.73 percent in the per-protocol analysis, compared with 84.20 percent in the esomeprazole group, a difference that reached statistical significance at P equals 0.04. Although the intention-to-treat and modified intention-to-treat analyses showed the same directional advantage for the vonoprazan regimen, those comparisons did not cross the threshold of statistical significance, a nuance the authors attribute in part to the non-randomized design and the modest sample size. Still, a cure rate approaching 98 percent in patients who completed the prescribed course places the vonoprazan dual approach among the most effective antibiotic-sparing strategies reported, comfortably exceeding the 90 percent benchmark that international consensus guidelines set for first-line eradication therapy.

Equally important for practice, the safety and tolerability picture was essentially identical between arms. Adverse reactions, which in dual amoxicillin regimens typically include diarrhea, nausea, taste disturbances, rash, and abdominal discomfort, occurred at comparable frequencies in the two groups, and patient compliance did not differ significantly between the P-CAB and PPI regimens. Neither regimen caused treatment-related events severe enough to disrupt the comparison, suggesting that the pharmacological intensity of vonoprazan did not translate into a clinical tolerability penalty. For gastroenterologists weighing first-line options, this aligns the choice more squarely on efficacy grounds, since the operational burden of four-times-daily amoxicillin dosing applies to both regimens equally.

The microbiota component of the study adds a layer of ecological context that eradication trials rarely capture. Using 16S rRNA gene amplicon sequencing of the V3 and V4 hypervariable regions, the team quantified alpha diversity, assessed community structure with principal co-ordinates analysis, and predicted functional shifts against the Kyoto Encyclopedia of Genes and Genomes reference pathways. Both eradication regimens delivered a discernible shock to the gut ecosystem: microbial diversity declined after treatment, community composition shifted measurably away from baseline and from the healthy control profile, and predicted metabolic pathways were transiently perturbed. Importantly, these disturbances followed a recovery trajectory over the follow-up period, with communities migrating back toward their pretreatment configuration by week six.

The two regimens left subtly different ecological fingerprints. The early decline in microbial diversity was more pronounced in the vonoprazan group, an observation consistent with the deeper and more sustained acid suppression that P-CABs deliver, since gastric acid and its downstream influence on the entire intestinal milieu shape which microbes survive transit into the lower gut. Yet the vonoprazan group also showed a tendency toward faster restoration of functional pathway profiles, hinting that the compositional damage and the functional damage may recover on different clocks. Across both arms, the researchers documented an increase in potential pathogenic bacteria and a corresponding decrease in short-chain fatty acid-producing bacteria after treatment, a pattern that matters because short-chain fatty acids such as butyrate fuel colonocytes, maintain epithelial barrier integrity, and exert anti-inflammatory signaling throughout the body. The fact that these SCFA producers rebounded over the six-week window will reassure clinicians, though the study’s design cannot exclude longer-lasting effects in some individuals.

The authors caution, appropriately, that the study was non-randomized, single-center, and modest in size, so the eradication difference should be interpreted as hypothesis-confirming rather than definitive, and the microbiota findings describe short-term dynamics only. Even so, the report lands at a moment when clinicians worldwide are retooling first-line H. pylori strategies amid rising antibiotic resistance. Vonoprazan-based dual therapy is already endorsed by growing bodies of guideline literature as a first-line option, and this comparison provides practical reassurance on two fronts simultaneously: it beats an optimized esomeprazole dual regimen where it counts, achieving eradication close to the theoretical ceiling while matching that regimen on safety and adherence, and the collateral microbiota damage it inflicts appears to be transient and self-repairing. For a bacterium that infects billions and drives one of the world’s most common cancers, treatment strategies that maximize cure rates while minimizing ecological and resistance costs represent exactly the kind of progress the field has been seeking, and this study offers a candid, quantified look at both sides of that bargain.

Subject of Research: Comparative efficacy of vonoprazan-based versus esomeprazole-based dual therapy for Helicobacter pylori eradication and short-term gut microbiota changes

Article Title: Comparative effects of vonoprazan-based and esomeprazole-based dual therapy on Helicobacter pylori eradication and short-term gut microbiota changes

Article References: Liu, Y., Qian, X., Yao, J., Fei, C., Zhang, Z., & Jiang, Z. (2026). Comparative effects of vonoprazan-based and esomeprazole-based dual therapy on Helicobacter pylori eradication and short-term gut microbiota changes. Gut Pathogens. https://doi.org/10.1186/s13099-026-00867-9

Image Credits: AI Generated

DOI: 10.1186/s13099-026-00867-9

Keywords: Helicobacter pylori, vonoprazan, esomeprazole, dual therapy, eradication, gut microbiota, 16S rRNA sequencing, potassium-competitive acid blocker, proton pump inhibitor, short-chain fatty acids, amoxicillin, 13C-urea breath test